George Elston - Chief Financial Officer at EyePoint Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
EYPT on Nasdaq
Industry
Laboratory Analytical Instruments
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by George Elston since 10/11/2024

Holdings reported by George Elston for EyePoint Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 62.1K $748K $12.04 Sep 19, 2025 Direct
Common Stock 20K $241K $12.04 Sep 19, 2025 By Family Trust
Restricted Stock Units 7.5K $0 $6.50 May 25, 2025 Direct Common Stock
Stock Option (Right to Buy) 117K Jan 3, 2025 Direct Common Stock

Transactions reported by George Elston for EyePoint Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.